Zobrazeno 1 - 10
of 21
pro vyhledávání: '"B E, KIRK"'
Autor:
B. E. Kirk, A P Craven, Michael George Lester, D Green, Panayiotis Alexandrou Procopiou, Chuen Chan, R A Henson, Brian Dymock, M J Bamford, Michael A. Snowden
Publikováno v:
Journal of Medicinal Chemistry. 38:3502-3513
A series of squalestatins modified at the C3-position with a heterocyclic functionality was prepared and evaluated in vitro as inhibitors of squalene synthase (SQS). Structure-activity relationships for compounds with the 4,6-dimethyloctenoate at C6(
Autor:
P A, Procopiou, E J, Bailey, M J, Bamford, A P, Craven, B W, Dymock, J G, Houston, J L, Hutson, B E, Kirk, A D, McCarthy, M, Sareen
Publikováno v:
Journal of Medicinal Chemistry. 37:3274-3281
Squalestatin analogues modified in the C1 side chain were prepared and evaluated for their ability to inhibit rat liver microsomal and Candida squalene synthase (SQS) in vitro. While maintaining the 4,6-dimethyloctenoate or 4,6-dimethyloctanoate este
Autor:
B. E. Kirk, Nigel S. Watson, Anton R. P. Srikantha, Julie L. Hutson, Brian Cox, Keeling Suzanne Elaine
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 4:1931-1936
A series of 3-hydroxymethyl derivatives of squalestatin 1 was prepared as inhibitors of squalene synthase. Potent in vitro inhibitory activity is retained in those analogues which possess C-6 and C-1 substituents analogous to those found in 1.
The squalestatins: potent inhibitors of squalene synthase. The role of the tricarboxylic acid moiety
Autor:
Nigel S. Watson, B. E. Kirk, Ian P. Steeples, Richard Bell, Chuen Chan, Julia Widdowson, Julie L. Hutson, Brian Cox, Keeling Suzanne Elaine, Panayiotis A. Procopiou
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 3:2541-2546
In squalestatins possessing at C6 either a 4,6-dimethyloctenoate ester or a hydroxyl group, the 5-carboxylic acid is crucial for squalene synthase inhibitory activity. In the former seires, free carboxylic acids are not required at C3 or C4 for poten
Autor:
Julie L. Hutson, D. F. Hayman, Chuen Chan, R. B. Lamont, P. S. Jones, B. E. Kirk, E. J. Bailey, Hartley Cd, Keeling Suzanne Elaine, Graham G. A. Inglis
Publikováno v:
Journal of Medicinal Chemistry. 36:3646-3657
3,5-Dihydroxy-7-(N-imidazolyl)heptanoates 4 and the corresponding heptenoates 5 were synthesized as novel classed of potent HMG-CoA reductase (HMGR) inhibitors in which members of the latter series possess enzyme inhibitory activity greater than that
Autor:
Keeling Suzanne Elaine, J. M. Pritchard, Julie L. Hutson, D. F. Hayman, Chuen Chan, Barry Clive Ross, Ian P. Steeples, B. E. Kirk, P. S. Jones, Nigel S. Watson, Graham George Adam Inglis, E. J. Bailey, Michael George Lester, Jan Josef Scicinski, C. D. Hartley, R. B. Lamont, G. Smith, Stephen J. Spooner
Publikováno v:
ChemInform. 25
Autor:
Richard Bell, B. E. Kirk, Chuen Chan, Keeling Suzanne Elaine, Julia Widdowson, Julie L. Hutson, Brian Cox, Nigel S. Watson, Panayiotis Alexandrou Procopiou, I. P. Stepples
Publikováno v:
ChemInform. 25
Autor:
C, Chan, E J, Bailey, C D, Hartley, D F, Hayman, J L, Hutson, G G, Inglis, P S, Jones, S E, Keeling, B E, Kirk, R B, Lamont
Publikováno v:
Journal of medicinal chemistry. 36(23)
3,5-Dihydroxy-7-(N-imidazolyl)heptanoates 4 and the corresponding heptenoates 5 were synthesized as novel classes of potent HMG-CoA reductase (HMGR) inhibitors in which members of the latter series possess enzyme inhibitory activity greater than that
Autor:
B. E. Kirk, Janice M. Webster
Publikováno v:
Applied Microbiology. 28:17-21
A quantitative assay for lymphocytic choriomeningitis virus was developed and standardized. The assay is based on direct immunofluorescent staining of infected L-929 cell monolayers and enumeration of cells containing fluorescent viral antigens. Maxi
Autor:
B. E. Kirk, Janice M. Webster
Publikováno v:
Infection and Immunity. 10:516-519
A 24-h neutralization test that is based on fluorescent cell counting was used for the detection and quantitative determination of serum-neutralizing antibody against lymphocytic choriomeningitis virus. The earliest manifestation of serum-neutralizin